文献速递肺栓塞与肺血管病

叙事医学视角下的肺动脉高压患者与照护者负担:INSPECTIO意大利多中心观察研究

Understanding the burden of pulmonary arterial hypertension among patients and caregivers through narrative medicine: data from Italian multicentre observational INSPECTIO study
RSS 订阅 · BMJ Open Respiratory Research

INSPECTIO研究在29个意大利中心纳入186例已接受马西替坦和/或司来帕格联合治疗的成人肺动脉高压患者,在入组时和12个月时收集患者与照护者叙事,并与emPHasis-10问卷及临床数据关联分析。结果显示患者叙事与emPHasis-10评分具有一致性,V3时未提及家庭生活、有羞耻或孤立感、日常活动受限或呼吸困难、持续治疗相关问题的患者评分更高;62%患者在V3认为带病生活可控。照护者叙事显示从V1到V3对照护关系和PAH治疗的感知改善。

要点

  • 患者叙事内容与emPHasis-10评分具有一致性,可用于识别负担更重的患者。
  • V3时未提及家庭生活、有羞耻/孤立感、日常活动受限或持续治疗问题的患者评分更高。
  • 照护者从V1到V3对照护关系和PAH治疗的感知改善。

核心结论

  • 整合叙事、患者报告结局与临床数据有助于深入理解肺动脉高压对患者及照护者的影响。
  • 适当的支持与治疗管理对帮助患者应对疾病至关重要,叙事可作为改善管理的工具。

研究设计与样本

  • 前瞻性、观察性、多中心非干预性INSPECTIO研究,在29个意大利医院中心开展。
  • 纳入已接受马西替坦和/或司来帕格联合治疗的成人肺动脉高压患者;总体INSPECTIO研究纳入186例患者。
  • 在入组时(V1)和12个月时(V3)收集患者与照护者叙事,用MAXQDA软件分析并与emPHasis-10评分及临床数据关联。

主要发现

  • 186例患者中,96/186(52%)完成V1叙事,58/186(31%)完成V3叙事。
  • 54例照护者中,29/54(54%)完成V1叙事,16/54(30%)完成V3叙事。
  • V3时,未提及家庭生活、报告羞耻或孤立感、日常活动受限或呼吸困难、持续治疗相关问题的患者emPHasis-10评分更高。
  • V3时36/58(62%)患者描述带病生活可控。
  • 照护者叙事从V1到V3显示对照护关系和PAH治疗感知改善。

关键数值与推荐

  • 患者叙事完成率:V1为96/186(52%),V3为58/186(31%)。
  • 照护者叙事完成率:V1为29/54(54%),V3为16/54(30%)。
  • V3时36/58(62%)患者认为带病生活可控。

临床怎么用

  • 临床中可结合叙事内容与emPHasis-10评分识别负担更重的肺动脉高压患者。
  • 关注未提及家庭生活、有羞耻或孤立感、日常活动受限或持续治疗问题的患者并给予支持。
  • 重视照护者体验,照护者叙事可反映照护关系与治疗感知的变化。

局限性

  • 患者V3叙事完成率仅31%,照护者V3完成率仅30%,失访比例较高。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Introduction A key challenge in pulmonary arterial hypertension (PAH) research is assessing the specific impact of this condition on health-related quality of life (HRQoL), also considering the patient’s subjective experience and caregiving burden. The prospective, observational, multicentre Non-INterventional Study on Pulmonary arterial hypertension patients treated with macitentan and/or selexipag: ExperienCe from an ITalIan cOhort (INSPECTIO) study integrated narratives with patient-reported outcomes (PROs) and clinical data to gain deeper insight into patients’ experiences of PAH, also involving caregivers’ perspectives. Methods The study was conducted across 29 Italian hospital-based centres and enrolled adult patients with PAH already on treatment with macitentan and/or selexipag as part of combination therapy. A dedicated narrative collection was carried out within the larger study. Patient and caregiver narratives were collected at enrolment (visit 1; V1) and at 12 months (visit 3; V3), then analysed through MAXQDA software and correlated with emPHasis-10 questionnaire scores and clinical data. Results Out of the 186 patients enrolled in the overall INSPECTIO study, 96/186 (52%) completed the narrative at V1 and 58/186 (31%) at V3; 29/54 (54%) caregivers completed the narrative at V1 and 16/54 (30%) at V3. The analysis revealed an alignment between patient narratives and emPHasis-10 scores. Specifically, at V3, emPHasis-10 scores were higher for patients who did not mention their domestic life in narratives, reported feelings of shame or isolation, limitations or breathlessness also in daily activities and reported ongoing treatment-related issues. Nonetheless, at V3, 36/58 (62%) of patients described living with PAH as manageable. The care pathway showed a positive impact on caregivers: their narratives indicated a shift from V1 to V3, with improved perceptions of the care relationship and PAH therapies. Conclusion INSPECTIO is the first study to integrate narratives, PROs and clinical data in PAH research. Findings suggested that appropriate support and therapeutic management are crucial to help patients cope with the condition. Narratives have proven to be a valuable tool for understanding the impact of PAH and improving its management, providing insights that can inform a more patient-centred approach. Trial registration number NCT04567602 .

来源:BMJ Open Respiratory Research,查看原文。版权归原作者所有。

引用

  1. BMJ Open Respiratory Research:Understanding the burden of pulmonary arterial hypertension among patients and caregivers through narrative medicine: data from Italian multicentre observational INSPECTIO study

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。